Literature DB >> 30578302

Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Harlan N Bradford1, Sriram Krishnaswamy2,3.   

Abstract

The proteolytic conversion of factor V to factor Va is central for amplified flux through the blood coagulation cascade. Heterodimeric factor Va is produced by cleavage at three sites in the middle of factor V by thrombin, yielding an N terminus-derived heavy chain and a C terminus-derived light chain. Here, we show that light chain formation resulting from the C-terminal cleavage is the rate-limiting step in the formation of fully cleaved Va. This rate-limiting step also corresponded to and was sufficient for the ability of cleaved factor V to bind Xa and assemble into the prothrombinase complex. Meizothrombin, the proteinase intermediate in thrombin formation, cleaves factor V more slowly than does thrombin, resulting in a pronounced defect in the formation of the light chain. A ∼100-fold reduced rate of meizothrombin-mediated light chain formation by meizothrombin corresponded to equally slow production of active cofactor and an impaired ability to amplify flux through the coagulation cascade initiated in plasma. We show that this defect arises from the occlusion of anion-binding exosite 2 in the catalytic domain by the covalently retained propiece in meizothrombin. Our findings provide structural insights into the prominent role played by exosite 2 in the rate-limiting step of factor V activation. They also bear on how factor V is converted into a cofactor capable of assembling into prothrombinase.
© 2019 Bradford and Krishnaswamy.

Entities:  

Keywords:  blood clotting; coagulation factor; enzyme kinetics; factor V; hemostasis; proteolysis; proteolytic enzyme; prothrombinase; serine protease; thrombin

Mesh:

Substances:

Year:  2018        PMID: 30578302      PMCID: PMC6378960          DOI: 10.1074/jbc.RA118.006510

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  An extensive interaction interface between thrombin and factor V is required for factor V activation.

Authors:  T Myles; T H Yun; S W Hall; L L Leung
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

2.  Exosites determine macromolecular substrate recognition by prothrombinase.

Authors:  S Krishnaswamy; A Betz
Journal:  Biochemistry       Date:  1997-10-07       Impact factor: 3.162

3.  Assembly of prothrombinase complex.

Authors:  S Krishnaswamy; M E Nesheim; E L Pryzdial; K G Mann
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

Review 4.  Factor V.

Authors:  M E Nesheim; J A Katzmann; P B Tracy; K G Mann
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 5.  Prothrombin.

Authors:  K G Mann; J Elion; R J Butkowski; M Downing; M E Nesheim
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 6.  The clot thickens: clues provided by thrombin structure.

Authors:  M T Stubbs; W Bode
Journal:  Trends Biochem Sci       Date:  1995-01       Impact factor: 13.807

7.  Activation of human factor V by factor Xa and thrombin.

Authors:  D D Monkovic; P B Tracy
Journal:  Biochemistry       Date:  1990-02-06       Impact factor: 3.162

8.  Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273.

Authors:  M J Rabiet; B C Furie; B Furie
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

9.  Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.

Authors:  J Rosing; R F Zwaal; G Tans
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

10.  The factor V activation paradox.

Authors:  Thomas Orfeo; Nicole Brufatto; Michael E Nesheim; Hung Xu; Saulius Butenas; Kenneth G Mann
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.